Skip to content

A study to assess the clinical effects of Intercostal nerve block in the management of primary costosternal syndrome

A study to assess the effects of Intercostal nerve block in the management of primary costosternal syndrome.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/033919
Enrollment
17
Registered
2021-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint

Interventions

Intervention1: USG guided Intercostal nerve block: The study deals with Ultrasoundguided intercostal nerve block in the management of primary costosternal syndrome. Control Intervention1: None: Since

Sponsors

RGKar Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. Age >= 18 years b. Pain and tenderness over costochondral junction c. Pain score >= 4 on the numerical rating scale(NRS) on a daily basis

Exclusion criteria

Exclusion criteria: a. Congenital abnormalities of the chest wall b. Clinical evidence of Tietze Syndrome c. History of thoracotomy and presence of intercostal neuralgia d. Cardiopulmonary or other systemic causes of anterior chest wall pain e. Costosternal Syndrome secondary to other causes f. Contraindication or History of adverse reaction to anesthetic agents or corticosteroids. g. History of intervention or surgery for treatment of Primary Costosternal Syndrome h. Anatomical abnormality near target injection site. i. Untreated cutaneous infection, systemic illness, or immunocompromised state j. History of bleeding tendency or use of anticoagulants. k. Patientâ??s refusal. l. Improvement of pain with conservative managements.

Design outcomes

Primary

MeasureTime frame
Pain severity Numeric Rating ScaleTimepoint: Baseline 1 week 4 weeks 12 weeks

Secondary

MeasureTime frame
Chest wall Range of motionTimepoint: Baseline 1 week 4 weeks 12 weeks

Countries

India

Contacts

Public ContactDr Pankaj Kumar Mandal

R.G.Kar Medical College and Hospital

sagnik.sm@gmail.com9163846404

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026